Sun Pharmaceutical Industries informs about press release

26 Jul 2024 Evaluate

Sun Pharmaceutical Industries has informed that the company (which includes its subsidiaries and associate companies, ‘Sun Pharma’) has received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the treatment of severe alopecia areata. A copy of the press release on this update is enclosed, and it shall be released after submitting this intimation.

The above information is a part of company’s filings submitted to BSE.


Sun Pharma Inds. Share Price

1854.15 7.20 (0.39%)
07-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1854.15
Dr. Reddys Lab 1350.75
Cipla 1497.80
Lupin 2357.65
Zydus Lifesciences 1001.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.